Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Sci Rep ; 10(1): 14856, 2020 09 09.
Article in English | MEDLINE | ID: covidwho-1493156


The problem of indoor odors can greatly affect a room's occupants. To identify odorants and comprehensively evaluate emissions from wooden materials, emissions and odors from Choerospondias axillaris (Roxb.) Burtt et Hill with different moisture content percentages and lacquer treatments were investigated in this study. Thermal desorption-gas chromatography-mass spectroscopy/olfactometry was used to analyze the release characteristics. In total, 11 key odor-active compounds were identified as moisture content gradually decreased, concentrating between 15 and 33 min. Total volatile organic compounds, total very volatile organic compounds, and total odor intensity decreased as moisture content decreased. In addition, 35 odor-active compounds, including aromatics, alkenes, aldehydes, esters, and alcohols, were identified in the odor control list. Polyurethane (PU), ultraviolet (UV), and waterborne coatings had a good inhibitory effect on eight odor characteristics, but some scents arose after lacquer treatment. For equilibrium moisture content, the major characteristics of Choerospondias axillaris were fragrant (9.4) and mint-like (3.0) compared with the fragrant (8.2), fruity (7.8), and pleasant (5.8) characteristics of PU coating; the flowery (5.9), fragrant (5.0), glue-like (4.3), and pineapple-like (4.3) characteristics of UV coating; and the antiseptic solution (3.6), fragrant (2.9), cigarette-like (2.8), and fruity (2.5) characteristics of waterborne coating. Based on multicomponent evaluation, a Choerospondias axillaris board with waterborne coating was suggested for use indoors.

Anacardiaceae/chemistry , Odorants/analysis , Volatile Organic Compounds/analysis , Wood/chemistry , China , Humans , Lacquer , Olfactory Perception
Sci Rep ; 11(1): 8694, 2021 04 22.
Article in English | MEDLINE | ID: covidwho-1199314


Social and mental stressors associated with the pandemic of a novel infectious disease, e.g., COVID-19 or SARS may promote long-term effects on child development. However, reports aimed at identifying the relationship between pandemics and child health are limited. A retrospective study was conducted to associate the SARS pandemic in 2003 with development milestones or physical examinations among longitudinal measurements of 14,647 children. Experiencing SARS during childhood was associated with delayed milestones, with hazard ratios of 3.17 (95% confidence intervals CI: 2.71, 3.70), 3.98 (3.50, 4.53), 4.96 (4.48, 5.49), or 5.57 (5.00, 6.20) for walking independently, saying a complete sentence, counting 0-10, and undressing him/herself for urination, respectively. These results suggest relevant impacts from COVID-19 on child development should be investigated.

COVID-19/psychology , Child Development , Severe Acute Respiratory Syndrome/psychology , Child , Child, Preschool , China , Female , Humans , Infant , Male , Retrospective Studies
Natl Sci Rev ; 8(3): nwaa297, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-990776


Receptor recognition and subsequent membrane fusion are essential for the establishment of successful infection by SARS-CoV-2. Halting these steps can cure COVID-19. Here we have identified and characterized a potent human monoclonal antibody, HB27, that blocks SARS-CoV-2 attachment to its cellular receptor at sub-nM concentrations. Remarkably, HB27 can also prevent SARS-CoV-2 membrane fusion. Consequently, a single dose of HB27 conferred effective protection against SARS-CoV-2 in two established mouse models. Rhesus macaques showed no obvious adverse events when administrated with 10 times the effective dose of HB27. Cryo-EM studies on complex of SARS-CoV-2 trimeric S with HB27 Fab reveal that three Fab fragments work synergistically to occlude SARS-CoV-2 from binding to the ACE2 receptor. Binding of the antibody also restrains any further conformational changes of the receptor binding domain, possibly interfering with progression from the prefusion to the postfusion stage. These results suggest that HB27 is a promising candidate for immuno-therapies against COVID-19.